Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer.

ABSTRACT:

Background

Adjuvant therapy plays a major role in treating colorectal cancer, and physicians' views of its effectiveness influence treatment decisions. We assessed physicians' views of the relative benefits and risks of adjuvant chemotherapy and radiotherapy for stages II and III colon and rectal cancers.

Methods

The Cancer Care Outcomes Research and Surveillance Consortium surveyed a geographically dispersed population of medical oncologists, radiation oncologists, and surgeons in the United States about the benefits and risks of adjuvant therapies for colorectal cancer. We used logistic regression to assess the association of physician and practice characteristics with beliefs about adjuvant therapies.

Results

Among 1,296 respondents, > 90% believed the benefits of

SUBMITTER: Wong AC 

PROVIDER: S-EPMC4161733 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature